Get the Stockscreener App
1.27
3.79%
-0.05
Liminatus Pharma Inc stock is traded at $1.27, with a volume of 138.33K.
It is down -3.79% in the last 24 hours and down -26.59% over the past month.
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.
See More
Previous Close:
$1.32
Open:
$1.32
24h Volume:
138.33K
Relative Volume:
0.11
Market Cap:
$32.91M
Revenue:
-
Net Income/Loss:
$-1.40M
P/E Ratio:
-6.1234
EPS:
-0.2074
Net Cash Flow:
$-10.49M
1W Performance:
-10.56%
1M Performance:
-26.59%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$1.20
$1.33
1-Week Range:
$1.20
$1.70
52-Week Range:
$1.11
$33.66
Liminatus Pharma Inc Stock (LIMN) Company Profile
Name
Liminatus Pharma Inc
Sector
Industry
Phone
213-273-5453
Address
6 CENTERPOINTE DR., LA PALMA
Compare LIMN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
1.265 | 35.73M | 0 | -1.40M | -10.49M | -0.2074 |
|
VRTX
Vertex Pharmaceuticals Inc
|
428.42 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
631.32 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
426.61 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
842.02 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.88 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Liminatus Pharma Inc Stock (LIMN) Latest News
Is Liminatus Pharma Inc. stock entering bullish territoryQuarterly Performance Summary & Community Verified Watchlist Alerts - newser.com
What technical models suggest about Liminatus Pharma Inc.’s comebackGlobal Markets & Stepwise Trade Execution Plans - newser.com
Analyzing recovery setups for Liminatus Pharma Inc. Equity Warrant investors2025 Market Sentiment & Safe Entry Zone Tips - newser.com
Is Liminatus Pharma Inc. stock recession proofTrade Signal Summary & Free Accurate Trade Setup Notifications - newser.com
Signal strength of Liminatus Pharma Inc. stock in tech scannersEarnings Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Backtesting results for Liminatus Pharma Inc. trading strategiesJuly 2025 Pullbacks & Weekly Market Pulse Updates - newser.com
How strong is Liminatus Pharma Inc. stock revenue growthEarnings Overview Summary & Momentum Based Trading Signals - newser.com
Tools to assess Liminatus Pharma Inc. Equity Warrant’s risk profileQuarterly Growth Report & Capital Efficient Trading Techniques - newser.com
Technical analysis overview for Liminatus Pharma Inc. Equity Warrant stockJuly 2025 Summary & Risk Managed Investment Signals - newser.com
Analyzing Liminatus Pharma Inc. Equity Warrant with multi timeframe charts2025 Performance Recap & Community Verified Watchlist Alerts - newser.com
Will Liminatus Pharma Inc. Equity Warrant stock split attract more investorsMarket Trend Summary & Reliable Momentum Entry Alerts - newser.com
Using data models to predict Liminatus Pharma Inc. Equity Warrant stock movementJuly 2025 Price Swings & AI Based Buy and Sell Signals - newser.com
Long term hold vs stop loss in Liminatus Pharma Inc.Weekly Trading Summary & AI Forecast Swing Trade Picks - newser.com
Can Liminatus Pharma Inc. stock deliver consistent earnings growthJuly 2025 Fed Impact & High Yield Equity Trading Tips - newser.com
What momentum shifts mean for Liminatus Pharma Inc. Equity WarrantEarnings Recap Summary & High Return Stock Watch Alerts - newser.com
How Liminatus Pharma Inc. stock benefits from strong dollar2025 Key Highlights & Technical Pattern Based Signals - newser.com
Pattern recognition hints at Liminatus Pharma Inc. Equity Warrant upsideJuly 2025 PostEarnings & Safe Entry Zone Tips - newser.com
What risks investors should watch in Liminatus Pharma Inc. Equity Warrant stockJuly 2025 Levels & Weekly Return Optimization Alerts - newser.com
Why Liminatus Pharma Inc. Equity Warrant stock is seen as undervaluedMarket Activity Summary & Daily Profit Maximizing Trade Tips - newser.com
Can Liminatus Pharma Inc. Equity Warrant stock double in next 5 yearsMarket Movers & Safe Entry Point Alerts - newser.com
Multi factor analysis applied to Liminatus Pharma Inc.Weekly Gains Report & Risk Adjusted Buy/Sell Alerts - newser.com
Is Liminatus Pharma Inc. Equity Warrant stock a good choice for value investorsTrade Entry Report & Accurate Technical Buy Alerts - newser.com
Analyzing drawdowns of Liminatus Pharma Inc. Equity Warrant with statistical toolsJuly 2025 PreEarnings & Precise Swing Trade Entry Alerts - newser.com
How Liminatus Pharma Inc. stock reacts to Fed rate cutsGap Down & Daily Profit Maximizing Tips - newser.com
What analysts say about Liminatus Pharma Inc Equity Warrant stockRetail Investor Activity & Grow Smarter With Pro-Level Research - earlytimes.in
Is Liminatus Pharma Inc. Equity Warrant stock supported by strong cash flowsJuly 2025 Breakouts & Weekly High Potential Stock Alerts - newser.com
How to use Fibonacci retracement on Liminatus Pharma Inc. Equity WarrantEarnings Summary Report & Fast Moving Trade Plans - newser.com
Will Liminatus Pharma Inc. Equity Warrant stock deliver strong dividend growthPortfolio Gains Summary & Growth Focused Entry Point Reports - newser.com
Liminatus Pharma Inc Stock (LIMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.35%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):